What's new? Log in Free sign up

Protagenic Therapeutics (PTIX)

Company Profile

Company profile

Ticker

PTIX, PTIXW

Exchange

Website

www.protagenic.com

CEO

Dr. Garo H. Armen Ph.D.

Incorporated

Location

Fiscal year end

Sector

Health Technology > Biotechnology

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Alabama Power • Mississippi Power • Teva Pharmaceutical Industries Limited • Entergy Arkansas • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb ...

Former names

Atrinsic, Inc., MILLBROOK PRESS INC, MPLC, Inc., NEW MOTION, INC.

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Protagenic Therapuetics Canada ...

IRS number

61390025

PTIX stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

IPO registration

Preliminary proxy

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

Quarterly report

14 Nov 24

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Quarterly report

14 Aug 24

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard

Shelf registration

Latest ownership filings

View all

ARMISTICE CAPITAL, LLC

TIMOTHY R WRIGHT

Robert Benjamin Stein

Alexander K. Arrow

ARMISTICE CAPITAL, LLC

Alexander K. Arrow

Financial summary

Financial statements Chart PTIX financial data

Quarter (USD)	Sep 24	Jun 24	Dec 23	Sep 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

PTIX institutional ownership history Ownership history

2.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	6	12	-50.0%
Opened positions	2	11	-81.8%
Closed positions	8	0	NEW
Increased positions	0	0
Reduced positions	1	0	NEW

13F shares	Current	Prev Q	Change
Total value	37.54 mm	12.04 bn	-99.7%
Total shares	92.44 k	740.08 k	-87.5%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Susquehanna International	53.20 k	$24.64 mm	NEW
GTS Securities	25.30 k	$202.00 k	-0.4%
STT State Street	13.81 k	$12.68 mm	0.0%
BAC Bank of America	129.00	$27.00 k	NEW
MS Morgan Stanley	1.00	$1.00 k	0.0%
CWM	1.00	$0.00	0.0%
Proequities	0.00	$0.00

Largest transactions	Shares	Bought/sold	Change
Eagle Asset Management	0.00	-419.32 k	EXIT
Warberg Asset Management	0.00	-177.20 k	EXIT
Susquehanna International	53.20 k	+53.20 k	NEW
Vanguard	0.00	-33.17 k	EXIT
Geode Capital Management	0.00	-25.17 k	EXIT
Advisor	0.00	-21.41 k	EXIT
FNY Investment Advisers	0.00	-18.75 k	EXIT
Tower Research Capital	0.00	-5.81 k	EXIT
BAC Bank of America	129.00	+129.00	NEW
GTS Securities	25.30 k	-100.00	-0.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

PTIX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
25 Mar 24	Robert Benjamin Stein	PTIX Common stock Options PTIX Common Stock, Par Value $0.0001	Grant	Acquire A	No	No	1.74	75,000	130.50 k	75,000
25 Mar 24	Corvese Brian	PTIX Common stock Options PTIX Common Stock, Par Value $0.0001	Grant	Acquire A	No	No	1.74	43,750	76.13 k	43,750
25 Mar 24	Buell Jennifer	PTIX Common stock Options PTIX Common Stock, Par Value $0.0001	Grant	Acquire A	No	No	1.74	75,000	130.50 k	75,000
25 Mar 24	Khalil Barrage	PTIX Common stock Options PTIX common stock, Par Value $0.0001	Grant	Acquire A	No	No	1.74	22,500	39.15 k	22,500
25 Mar 24	Armen Garo H	PTIX Common stock Options PTIX Common Stock, Par Value $0.0001	Grant	Acquire A	No	No	1.74	250,000	435.00 k	250,000

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Protagenic Therapeutics Announces Pricing Of $1.275M Private Placement For The Purchase And Sale Of An Aggregate Of 1,948,295 Shares Of Common Stock; The Purchase Price Of Each Share Of Common Stock And Associated Common Stock Purchase Warrants Will Be $0.64

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, announced today it has entered into a purchase agreement (the "Purchase Agreement") for

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

Press releases

From Benzinga Pro

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, announced today that

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, announced today it

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.